BackgroundOligoarticular juvenile idiopathic arthritis (oJIA) is the most frequent form of chronic arthritis in children; the clinical course is extremely variable. In this study we have characterized by flow cytometry synovial B and T cells subsets in patients with oJIA in order to identify any parameters that could predict a more aggressive course of disease.MethodsB and T cells from synovial fluid (SF) of 39 patients with oJIA were characterized by flow cytometry. In 22 patients SF was analysed at the onset of the disease (GroupA), in 17 SF was analysed at articular relapse (Group B). All patients in Group A were followed up for at least for 2 years after SF analysis: 13 patients relapsed during the follow-up period.ResultsComparison of SF from Group A and Group B demonstrated an activated phenotype in relapsed patients, with higher Switched Memory B cells (58.53 vs 36.07% of CD19+, P-value 0.004) and lower Naive B cells (8.53 vs 25.9 of CD19+, P-value 0.002) in Group B. Furthermore, patients from Group A who did not relapse showed lower percentages of synovial DNT (2.38 vs 1.50% of CD3+TCRalpha/beta+, P-value 0.025) and T cells (19.1 vs 15.0% of CD3+ cells, P-value 0.004) at the onset, if compared with other Group A patients.ConclusionsIn oJIA relapse SF present an activated B phenotype. Patients at disease onset with DNTs <1.8% and/or T cells <16% of CD3+ in synovial fluid have longer free-disease survival. (c) 2017 International Clinical Cytometry Society

Low synovial double negative T and γδ T cells predict longer free-disease survival in oligoarticular JIA

Licciardi, Francesco
First
;
Ceci, Maria;Toppino, Claudia;Martino, Silvana;Montin, Davide
Last
2018-01-01

Abstract

BackgroundOligoarticular juvenile idiopathic arthritis (oJIA) is the most frequent form of chronic arthritis in children; the clinical course is extremely variable. In this study we have characterized by flow cytometry synovial B and T cells subsets in patients with oJIA in order to identify any parameters that could predict a more aggressive course of disease.MethodsB and T cells from synovial fluid (SF) of 39 patients with oJIA were characterized by flow cytometry. In 22 patients SF was analysed at the onset of the disease (GroupA), in 17 SF was analysed at articular relapse (Group B). All patients in Group A were followed up for at least for 2 years after SF analysis: 13 patients relapsed during the follow-up period.ResultsComparison of SF from Group A and Group B demonstrated an activated phenotype in relapsed patients, with higher Switched Memory B cells (58.53 vs 36.07% of CD19+, P-value 0.004) and lower Naive B cells (8.53 vs 25.9 of CD19+, P-value 0.002) in Group B. Furthermore, patients from Group A who did not relapse showed lower percentages of synovial DNT (2.38 vs 1.50% of CD3+TCRalpha/beta+, P-value 0.025) and T cells (19.1 vs 15.0% of CD3+ cells, P-value 0.004) at the onset, if compared with other Group A patients.ConclusionsIn oJIA relapse SF present an activated B phenotype. Patients at disease onset with DNTs <1.8% and/or T cells <16% of CD3+ in synovial fluid have longer free-disease survival. (c) 2017 International Clinical Cytometry Society
2018
94
3
423
427
DNT; JIA; prognostic factor; γδ T cells; Antigens, CD19; Arthritis, Juvenile; B-Lymphocytes; Child; Child, Preschool; Disease-Free Survival; Female; Flow Cytometry; Humans; Male; Synovial Fluid; T-Lymphocyte Subsets
Licciardi, Francesco; Ceci, Maria; Toppino, Claudia; Turco, Marco; Martino, Silvana; Ricotti, Emanuela; Ferro, Francesca; Montin, Davide
File in questo prodotto:
File Dimensione Formato  
Cytometry Part B Clinical - 2017 - Licciardi - Low synovial double negative T and T cells predict longer free‐disease.pdf

Accesso riservato

Dimensione 188.61 kB
Formato Adobe PDF
188.61 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1878327
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact